David Antonio Medina MD

Psychiatry•Orlando, FL

Geriatric Psychiatry, Neuropsychiatry, Psychopharmacology

Nova Psychiatry, Inc.

Join to View Full Profile

1836 Woodward StreetOrlando, FL 32803
Phone+1 407-894-6980
Fax+1 407-894-6982

Summary

Dr. David Medina is a psychiatrist located in Orlando, FL. He received his medical degree from Central University of Venezuela and has been a psychiatrists for 25 years. Besides English-speaking patients, he treats others that speak Spanish and Portuguese. He specializes in geriatric psychiatry, neuropsychiatry, and psychopharmacology and is experienced in the treatment of Schizophrenia, Mood disorders (Bipolar and Depressive disorders), Anxiety disorders, PTSD & OCD; and the neuropsychiatric and behavioral disturbances secondary to neurodegenerative diseases such Alzheimer's disease and Parkinson's disease (and related conditions), as well as Autism and intellectual disabilities, acquired Brain injury (including secondary to stroke), and delirium. He has several publications and 42 citings.

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Psychiatry, 2008 - 2012
Central University of VenezuelaClass of 1994

Certifications & Licensure

FL State Medical License 2012 - 2026
OH State Medical License 2008 - 2026
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02) Start of enrollment: 2016 Nov 01
Completed
Phase 3
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder Start of enrollment: 2016 Nov 13
Completed
Phase 3
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder Start of enrollment: 2017 Feb 03
Completed
Phase 3
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression Start of enrollment: 2019 Sep 26
RECRUITING
NA
Real-life Effectiveness of Vortioxetine in Depression Start of enrollment: 2017 Nov 17
Completed
A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite® Start of enrollment: 2019 Apr 29
Terminated
Phase 3
Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS) Start of enrollment: 2019 Mar 28
Completed
CONNEX-3: A Study to Test Whether Iclepertin Improves Learning and Memory in People With Schizophrenia Start of enrollment: 2021 Aug 09
COMPLETED
PHASE3
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant Start of enrollment: 2020 Sep 16
COMPLETED
PHASE3
Join now to see all

Publications & Presentations

PubMed

42 citations
Diffusion tensor imaging investigations in Alzheimer's disease: the resurgence of white matter compromise in the cortical dysfunction of the aging brain.
David A Medina, Moises Gaviria
Neuropsychiatric Disease and Treatment. 2008-08-08

Professional Memberships

American Psychiatric Association - APA
Fellow
Florida Psychiatric Society
Member

Other Languages

Spanish